Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot Study

Lemchukwu Amaeshi   ^{1, 2} , MD ;   Lauren Laufer   ^{1, 3} , BA, MD ;   Kateryna Fedorov   ^{4, 5} , MD ;   Alex Sisto   ^{1, 6} , MD ;   David Levitz   ⁴ , MD ;   Rosmi Mathew   ¹ , DNP, APRN, FNP-BC ;   Karen Wright   ^{1 †} , RN, MS ;   Dennis Cooper   ⁴ , MD ;   Mendel Goldfinger   ⁴ , MD ;   Ioannis Mantzaris   ⁴ , MD ;   R Alejandro Sica   ⁴ , MD ;   Kira Gritsman   ⁴ , MD, PhD ;   Marina Konopleva   ^{4, 7} , MD, PhD ;   Ridhi Gupta   ⁴ , MD ;   Noah Kornblum   ⁴ , MD ;   Chenxin Zhang   ² , MS ;   Mimi Kim   ² , SCD ;   Amit Verma   ⁴ , MD ;   Bruce Rapkin   ^{1, 2} , PhD ;   Aditi Shastri   ⁴ , MD ;   Nishi Shah   ⁴ , MD, MPH

¹ Department of Medicine, Montefiore Medical Center, Bronx, NY, United States

² Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, United States

³ Department of Medicine, University of California, Los Angeles, CA, United States

⁴ Department of Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY, United States

⁵ Oncology, Vanderbilt University Medical Center, Nashville, TN, United States

⁶ Department of Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, United States

⁷ Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States

†deceased